Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40018067
Localisation
United Kingdom
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
11/09/2025
Statut
Classification
1.5°C
Année cible
2033
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Bespak commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Bespak commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by 2033 from a 2020 base year. Bespak also commits to reduce scope 3 GHG emissions 61.07% per GBP value added by 2033 from a 2023 base year. Long-Term Targets: Bespak commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2020 base year. Bespak also commits to reduce scope 3 GHG emissions 97.0% per GBP value added by 2050 from a 2023 base year.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques